Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ASCO Annual Meeting 2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

2024 ASCO Annual Meeting

Keep up to date with all the top stories and latest evidence with our hub page, including official congress videos and expert takeaways.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 11/2013

01-11-2013 | Letter

Impact of impaired insulin secretion and insulin resistance on the incidence of diabetes in a Japanese cohort. Reply to Yamauchi K and Aizawa T [letter]

Authors: Akiko Morimoto, Yukako Tatsumi, Kijyo Deura, Naomi Miyamatsu, Mitsuhiko Noda, Shaw Watanabe

Published in: Diabetologia | Issue 11/2013

Login to get access

Excerpt

To the Editor: We appreciate the comments from Dr Yamauchi and Dr Aizawa [1] on our recent publication in Diabetologia [2]. We sincerely respond to their concerns as follows. …
Literature
1.
Yamauchi K, Aizawa T (2013) Impact of impaired insulin secretion and insulin resistance on the incidence of diabetes in a Japanese cohort. Diabetologia. doi:10.​1007/​s00125-013-3046-2
2.
Morimoto A, Tatsumi Y, Deura K et al (2013) Impact of impaired insulin secretion and insulin resistance on the incidence of type 2 diabetes mellitus in a Japanese population: the Saku study. Diabetologia 56:1671–1679PubMedCrossRef
3.
Tripathy D, Almgren P, Tuomi T, Groop L (2004) Contribution of insulin-stimulated glucose uptake and basal hepatic insulin sensitivity to surrogate measures of insulin sensitivity. Diabetes Care 27:2204–2210PubMedCrossRef
4.
DeFronzo RA, Ferrannini E (1991) Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173–194PubMedCrossRef
5.
Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature 14:840–846CrossRef
Metadata
Title
Impact of impaired insulin secretion and insulin resistance on the incidence of diabetes in a Japanese cohort. Reply to Yamauchi K and Aizawa T [letter]
Authors
Akiko Morimoto
Yukako Tatsumi
Kijyo Deura
Naomi Miyamatsu
Mitsuhiko Noda
Shaw Watanabe
Publication date
01-11-2013
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 11/2013
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-013-3068-9

Other articles of this Issue 11/2013

Diabetologia 11/2013 Go to the issue

Research Letter

High frequency of autoantibodies in patients with long duration type 1 diabetes

Article

Metformin action in human hepatocytes: coactivation of atypical protein kinase C alters 5′-AMP-activated protein kinase effects on lipogenic and gluconeogenic enzyme expression

Short Communication

Does metformin modify the effect on glycaemic control of aerobic exercise, resistance exercise or both?

Letter

Impact of impaired insulin secretion and insulin resistance on the incidence of diabetes in a Japanese cohort

Letter

The diagnosis of insulitis in human type 1 diabetes

Short Communication

Time trends in mortality rates in type 1 diabetes from 2002 to 2011
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Image Credits